| (CNY) | Mar 2022 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 22.53M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 300267.SZ returned -22.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -7.0% |
| 1 year | -22.3% |
| 5 years | -16.5% |
| 10 years | -76.6% |
| All-time high | ¥18.43 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 300267.SZ would be worth today ›No. Hunan Er-Kang Pharmaceutical Co., Ltd has not paid a dividend in the past 12 months.
Hunan Er-Kang Pharmaceutical Co., Ltd is part of the Healthcare sector.
Hunan Er-Kang Pharmaceutical Co., Ltd has a market cap of 6.54B CNY, based on the latest quote.
